Silo Pharma, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

64.59 k

Shareholding (Mar 2025)

FII

0.46%

Held by 2 FIIs

DII

95.41%

Held by 4 DIIs

Promoter

0.00%

How big is Silo Pharma, Inc.?

22-Jun-2025

As of Jun 18, Silo Pharma, Inc. has a market capitalization of 4.35 million, with net sales of 0.08 million and a net profit of -4.62 million over the last four quarters. The company's shareholder's funds are 5.03 million, and total assets are 7.41 million.

What does Silo Pharma, Inc. do?

22-Jun-2025

Silo Pharma, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $1 million as of March 2025, with a market cap of $4.35 million. Key financial metrics indicate it is loss-making with a negative return on equity of -115.21%.

Is Silo Pharma, Inc. technically bullish or bearish?

20-Sep-2025

As of August 1, 2025, Silo Pharma, Inc. is in a mildly bearish trend, with daily indicators showing bearish signals, while it has underperformed the S&P 500 significantly with a year-to-date return of -20.60%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 6 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.27

Return on Equity

-99.55%

Price to Book

1.14

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-27.68%

6 Months

-8.94%

1 Year

-54.85%

2 Years

-68.86%

3 Years

-87.14%

4 Years

173.64%

5 Years

-97.97%

Silo Pharma, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Silo Pharma, Inc. technically bullish or bearish?

As of 1 August 2025, the technical trend for Silo Pharma, Inc. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators such as the daily moving averages indicating a mildly bearish outlook. While the weekly MACD and KST show mildly bullish signals, the monthly indicators, including the moving averages and Dow Theory, are bearish. The stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -20.60% versus the S&P's 12.22%, and a one-year return of -30.72% compared to the S&P's 17.14%....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.59%

EBIT Growth (5y)

-201.83%

EBIT to Interest (avg)

-3.73

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.36

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.48%

ROCE (avg)

ROE (avg)

10.06%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.04

EV to EBIT

0.25

EV to EBITDA

0.25

EV to Capital Employed

0.88

EV to Sales

-1.26

PEG Ratio

Dividend Yield

ROCE (Latest)

346.05%

ROE (Latest)

-115.21%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 3 Schemes (4.13%)

Foreign Institutions

Held by 2 Foreign Institutions (0.46%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -20.00% vs 41.18% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.20",
          "val2": "-1.10",
          "chgp": "-9.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "-1.00",
          "chgp": "-20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-69,267.70%",
          "val2": "-60,696.80%",
          "chgp": "-857.09%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -22.22% vs 7.69% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.70",
          "val2": "-3.90",
          "chgp": "-20.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.40",
          "val2": "-3.60",
          "chgp": "-22.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-65,264.40%",
          "val2": "-53,474.10%",
          "chgp": "-1,179.03%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.20

-1.10

-9.09%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-1.20

-1.00

-20.00%

Operating Profit Margin (Excl OI)

-69,267.70%

-60,696.80%

-857.09%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -20.00% vs 41.18% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.10

Operating Profit (PBDIT) excl Other Income

-4.70

-3.90

-20.51%

Interest

0.00

Exceptional Items

0.00

-0.20

100.00%

Consolidate Net Profit

-4.40

-3.60

-22.22%

Operating Profit Margin (Excl OI)

-65,264.40%

-53,474.10%

-1,179.03%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -22.22% vs 7.69% in Dec 2023

All Annual Results

Company CV

About Silo Pharma, Inc.

Silo Pharma, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Silo Pharma, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Silo Pharma, Inc.?

Watch in Real-Time

What does Silo Pharma, Inc. do?

Is Silo Pharma, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Silo Pharma, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Silo Pharma, Inc.

Company Coordinates